Aussetzung der geistigen Eigentumsrechte an Impfstoffen gegen Covid-19 durch die Welthandelsorganisation

This question concerns the World Trade Organization's (WTO) decision to temporarily suspend intellectual property rights for COVID-19 vaccines. It addresses the implications of this waiver for vaccine accessibility and global health equity. The procedure focuses on the impact of the TRIPS waiver on vaccine production and distribution, particularly for developing countries, and its potential effects on pharmaceutical innovation and future pandemic preparedness.